10 Ways To Reinvent Your Xarelto Lawsuit
Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered significant bleeding events. Pharmaceutical companies, such as the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to do so could be grounds for compensation. Our lawyers are working difficult to acquire these hurt by the drug the compensation they may be entitled to.
Even though bleeding is really a typical complication linked with anticoagulants, it has been alleged that Xarelto is much more harmful than traditional blood thinners since no antidote exists to reverse its blood-thinning effects. This signifies that, in the event of an emergency, patients could be at threat for irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging.
In the event you or a loved 1 suffered a critical bleeding occasion soon after taking Xarelto, you may have legal recourse. For much more information, make contact with us nowadays to have your case reviewed, cost-free of charge.
Compensation Possibilities
xarelto-compensation-photoThe plaintiffs in these lawsuits are searching for compensation from Bayer and Janssen for past and future medical bills, lost wages, pain and suffering and, in cases of death, funeral expenses. Moreover, they are looking for punitive damages, which are usually awarded to punish the defendant and deter other firms from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is harmful and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective http://mybookmarks.com/public/rcfried/exo_folders/file:///C:/Documents implies of stopping Xarelto users from bleeding inside the event of an emergency. Plaintiffs in the lawsuits allege serious and fatal injuries, like cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a secure anticoagulant option.
Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.
Visit this page for more information on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
